Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains
Year: 2021
Type: article
Abstract: Alzheimer's disease (AD) is the leading cause of dementia in aging individuals. Yet, the pathophysiological processes involved in AD onset and progression are still poorly understood. Among numerous strategies, a comprehensive overview of gene expression alterations in the diseased brain could contribute for a better understanding of the AD pathology. In this work, we probed the differential expression of genes in different brain regions of healthy and AD adult subjects using data from three large transcriptomic studies: Mayo Clinic, Mount Sinai Brain Bank (MSBB), and ROSMAP. Using a combination of differential expression of gene and isoform switch analyses, we provide a detailed landscape of gene expression alterations in the temporal and frontal lobes, harboring brain areas affected at early and late stages of the AD pathology, respectively. Next, we took advantage of an indirect approach to assign the complex gene expression changes revealed in bulk RNAseq to individual cell types/subtypes of the adult brain. This strategy allowed us to identify previously overlooked gene expression changes in the brain of AD patients. Among these alterations, we show isoform switches in the AD causal gene amyloid-beta precursor protein (APP) and the risk gene bridging integrator 1 (BIN1), which could have important functional consequences in neuronal cells. Altogether, our work proposes a novel integrative strategy to analyze RNAseq data in AD and other neurodegenerative diseases based on both gene/transcript expression and regional/cell-type specificities.
Authors: Diego Marques-Coelho, Lukas da Cruz Carvalho Iohan, Ana Raquel Melo de Farias, Amandine Flaig, The Brainbank Neuro–CEB Neuropathology Network, Franck Letournel, Marie-Laure Martin-Négrier, Françoise Chapon, Maxime Faisant, Catherine Godfraind, Claude-Alain Maurage, Vincent Deramecourt, Mathilde Duchesne, David Meyronnet, Nathalie Streichenberger, André Mauès de Paula, Valérie Rigau, Fanny Vandenbos-Burel, Charles Duyckaerts, Danielle Seilhean, Serge Milin, Dan Christian Chiforeanu, Annie Laquerrière, Florent Marguet, Béatrice Lannes, Jean-Charles Lambert, Marcos Romualdo Costa
Institutions: Universidade Federal do Rio Grande do Norte, Inserm, Université de Lille, Institut Pasteur de Lille, Centre Hospitalier Universitaire d'Angers, Hôpital Pellegrin, Centre Hospitalier Universitaire de Caen Normandie, Centre Hospitalier Universitaire de Clermont-Ferrand, Centre Hospitalier Universitaire de Lille, Hôpital Roger Salengro, Hôpital Universitaire Dupuytren, Hospices Civils de Lyon, Hôpital de la Timone, Centre Hospitalier Universitaire de Montpellier, Hôpital Pasteur, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Poitiers, Hôpital Pontchaillou, Hôpital Charles-Nicolle, Hôpital d'Hautepierre
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,090
Funders: Michael J. Fox Foundation for Parkinson's Research, Mayo Clinic, Illinois Department of Public Health, Mayo Foundation for Medical Education and Research, Arizona Department of Health Services, CurePSP, Rush University, Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease, Translational Genomics Research Institute, European Commission, Agence Nationale de la Recherche, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Arizona Biomedical Research Commission, Medical Research Council, European Regional Development Fund, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: G1052080286, Epidemiologic Study of Neural Reserve and Neurobiology of Aging, G1258278173, G1576660248, G1606131442, G1999460359, G2079542735, G2161113364, G2345704987, G2387188009, G250893170, Gene discovery in PSP by transcriptome, neuropathology and sequence analysis, G2898431357, Plasma AB as a Surrogate Genetic Marker for LOAD, G3250808129, G3251040009, G3255618601, Développement de stratégies innovantes pour une approche transdisciplinaire de la maladie d'Alzheime, G3521153818, G3687506083, Alzheimers Disease Patient Registry, Einstein Aging Study, G4369927624, G4440353152, G4741916379, G4791902628, Risk Factors, Pathology, and Clinical Expressions of AD, G5018925220, Rush Alzheimer's Disease Core Center, G541333419, G5484535055, G5713958695, G6030318873, G6125194395, Florida Alzheimer's Disease Research, G6720564865, G6814118465, G6875889451, Genome wide association study of gene expression levels in Alzheimer's disease, Arizona Alzheimer's Disease Core Center, G7161884846, Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences, Tau and Neurodegeneration II: A therapeutic target, A Systems Approach to Targeting Innate Immunity in AD, National Brain and Tissue Resource for Parkinson's Disease and Related Disorders, G7747731141, G7836467104, G7887587830, G8346902290, G837617365, G8762639507, G947960016, Mayo Alzheimer's Disease Research Center, G961669115, G989695202
OpenAlex ID: W3120777691
